Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Stimulants01:29

Stimulants

1.4K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.4K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

706
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
706
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

300
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
300
Global Regulatory Systems01:28

Global Regulatory Systems

959
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
959
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.3K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and correlates of e-cigarette use among older adults aged 60 years and over.

European geriatric medicine·2026
Same author

Comparing the Effect of Scaling and Polishing on Nine Oral Health and Dental Aesthetic Measures between Current and Never Smokers from the SMILE Study Cohort.

Journal of dentistry·2026
Same author

Association between electronic cigarette use and prediabetes, diabetes, and insulin resistance: a systematic review and meta-analysis.

Internal and emergency medicine·2026
Same author

Cigarette smoking, e-cigarette use, and hypertension: a population-based cross-sectional study.

Journal of human hypertension·2026
Same author

Differential associations of traditional and shape-based adiposity indices with steatosis and fibrosis risk in metabolic dysfunction-associated steatotic liver disease.

Journal of endocrinological investigation·2026
Same author

Finerenone in Cardiorenal Disease: A Narrative Review of Molecular Mechanisms, Clinical Evidence, and Emerging Therapeutic Roles.

Cardiovascular drugs and therapy·2026
Same journal

Frailty and its association with mental health and quality of life in multiple sclerosis: A cross-sectional study.

Therapeutic advances in chronic disease·2026
Same journal

Factors associated with disease knowledge and medication adherence among rheumatoid arthritis patients attending a private rheumatology clinic: A cross-sectional study.

Therapeutic advances in chronic disease·2026
Same journal

The evolving roles of fetuin-A in type 2 diabetes mellitus and its potential clinical implications: a review.

Therapeutic advances in chronic disease·2025
Same journal

Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication.

Therapeutic advances in chronic disease·2025
Same journal

Staging and markers in Parkinson's disease and Lewy body disorders: narrative review.

Therapeutic advances in chronic disease·2025
Same journal

A narrative review on the safety of glatiramer acetate in multiple sclerosis: focus on Europe.

Therapeutic advances in chronic disease·2025
See all related articles

Related Experiment Video

Updated: May 2, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

29.0K

Achieving appropriate regulations for electronic cigarettes.

Daniela Saitta1, Giancarlo Antonio Ferro2, Riccardo Polosa3

  • 1Department of Clinical and Molecular Biomedicine, University of Catania, Catania, Italy.

Therapeutic Advances in Chronic Disease
|March 4, 2014
PubMed
Summary
This summary is machine-generated.

Electronic cigarettes (e-cigarettes) show promise as a safer alternative to tobacco, but require careful regulation. This review examines current e-cigarette regulations, offering recommendations to protect public health while minimizing unintended consequences.

Keywords:
cigarette smokingelectronic cigarettesnicotine useregulationregulatory agenciestobacco harm reduction

More Related Videos

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.4K
Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

11.0K

Related Experiment Videos

Last Updated: May 2, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

29.0K
A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.4K
Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

11.0K

Area of Science:

  • Public Health
  • Tobacco Control
  • Regulatory Science

Background:

  • E-cigarettes are increasingly popular as a substitute for traditional tobacco cigarettes.
  • Their growing market share raises concerns among health professionals, regulators, and governments.
  • Effective regulation is crucial to protect users and the public.

Purpose of the Study:

  • To provide an overview of current and proposed regulations for e-cigarettes.
  • To critically evaluate existing regulatory decisions based on scientific evidence.
  • To propose evidence-based recommendations for e-cigarette regulation.

Main Methods:

  • Review of existing scientific literature on e-cigarettes and their health impacts.
  • Analysis of current regulatory frameworks and proposed deeming regulations.
  • Assessment of potential unintended consequences of regulatory actions.

Main Results:

  • Scientific evidence suggests e-cigarettes may reduce exposure to harmful smoke constituents.
  • Current regulatory approaches vary, with potential for unintended public health impacts.
  • A need exists for regulations informed by comprehensive scientific research.

Conclusions:

  • E-cigarette regulation requires a balanced approach, considering both potential benefits and risks.
  • Recommendations are proposed to optimize public health outcomes and mitigate regulatory challenges.
  • Further research is essential to guide evidence-based policy decisions.